학술논문

Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 1 2005, 23 4, p889-p898, 10p.
Subject
Language
English
ISSN
0732183X